Summit Therapeutics
SMMT
NASDAQ
IPO2015
about SMMT
Summit Therapeutics is a biopharmaceutical company focused on advancing novel therapies for rare diseases, with a diverse pipeline of clinical-stage programs targeting conditions with significant unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.68 | $16.21 | $15.66 | $11.9B | 2.45M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.31 | n/a | n/a | 0% | 0% | 0% |